Cointime

Anaphore

company

About

Anaphore develops protein therapeutics that address unmet medical needs of patients with life-threatening diseases.

  • 11 - 50

Highlights

Total Funding Amount
$46M
Funding Rounds
3
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$25M
Industries
Biotechnology,Medical Device,Therapeutics
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Anaphore (formerly ImmunoNewCo) is developing a new class of protein therapeutics to address significant unmet medical needs for patients with serious or life-threatening diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$46M
Anaphore has raised a total of $46M in funding over 2 rounds. Their latest funding was raised on Jun 9, 2009 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 9, 2009 Series A $13M 1 — — Detail
Jan 7, 2009 Series A $25M 1 Versant Ventures — Detail
Apr 15, 2008 Series Unknown $8M 1 Versant Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Anaphore is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures — Series A
Cointime
เนื้อหา
บริษัท